Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. Biomol Biomed [Internet]. 2019 Aug. 20 [cited 2024 Apr. 28];19(3):227-33. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/4204